- Filed
- Aug 1, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Jul 25, 2024 | 121.77M sh |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $169.17M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $247.59M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $640.16M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $594.21M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $859.97M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $766.33M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $904.48M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $788.73M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $351.19M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2023 | $616.26M |
| Shares Diluted restated | Q2 2024 · Jun 30, 2023 | 119.32M sh |
| Shares Diluted restated | Q2 2024 · Jun 30, 2023 | 116.59M sh |
| Capex | Q2 2024 · Jun 30, 2023 | $631K |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | −$327.78M |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $345.4M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $412.12M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $169.87M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$1.02 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$2.57 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$1.02 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$2.57 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $111.37M |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $213.47M |
| Rd Expense | Q2 2024 · Jun 30, 2023 | $95.66M |
| Rd Expense | Q2 2024 · Jun 30, 2023 | $205.68M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$122.04M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$299.82M |
| Net Income | Q2 2024 · Mar 31, 2023 | −$177.78M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$120.44M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$295.52M |
| Revenue | Q2 2024 · Jun 30, 2023 | $94.97M |
| Revenue | Q2 2024 · Jun 30, 2023 | $139.81M |